Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Renal and cardiovascular effects of selective cyclooxygenase-2 inhibitors.

Komers R, Anderson S, Epstein M.

Am J Kidney Dis. 2001 Dec;38(6):1145-57. Review.

PMID:
11728945
2.

Cyclooxygenase-2 inhibition and renal physiology.

Harris RC Jr.

Am J Cardiol. 2002 Mar 21;89(6A):10D-17D. Review.

PMID:
11909556
3.

[Selective inhibitors of type 2 cyclooxygenase: less renal effects than the classical non-steroidal anti-inflammatory agents].

Chiolero A, W├╝rzner G, Burnier M.

Nephrologie. 2000;21(8):425-30. Review. French.

PMID:
11213386
4.

Renal effects of cyclooxygyenase-2-selective inhibitors.

Brater DC.

J Pain Symptom Manage. 2002 Apr;23(4 Suppl):S15-20; discussion S21-3. Review.

PMID:
11992745
5.

[Recent development of selective cyclooxygenase-2 inhibitors].

Kawai S.

Nihon Rinsho. 2002 Dec;60(12):2370-7. Review. Japanese.

PMID:
12510364
6.

Cyclooxygenase-2 selective inhibitors and the kidney.

Breyer MD, Hao C, Qi Z.

Curr Opin Crit Care. 2001 Dec;7(6):393-400. Review.

PMID:
11805541
7.

Osteoarthritis therapy--are there still unmet needs?

Laufer S.

Rheumatology (Oxford). 2004 Feb;43 Suppl 1:i9-15. Review.

PMID:
14752170
8.
9.
10.

Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet. A randomized, controlled trial.

Swan SK, Rudy DW, Lasseter KC, Ryan CF, Buechel KL, Lambrecht LJ, Pinto MB, Dilzer SC, Obrda O, Sundblad KJ, Gumbs CP, Ebel DL, Quan H, Larson PJ, Schwartz JI, Musliner TA, Gertz BJ, Brater DC, Yao SL.

Ann Intern Med. 2000 Jul 4;133(1):1-9.

PMID:
10877734
11.

Coxibs--beyond the GI tract: renal and cardiovascular issues.

DeMaria AN, Weir MR.

J Pain Symptom Manage. 2003 Feb;25(2 Suppl):S41-9. Review.

PMID:
12604156
12.

Use of nonsteroidal anti-inflammatory drugs in patients with cardiovascular disease: a cautionary tale.

Amer M, Bead VR, Bathon J, Blumenthal RS, Edwards DN.

Cardiol Rev. 2010 Jul-Aug;18(4):204-12. doi: 10.1097/CRD.0b013e3181ce1521. Review.

PMID:
20539104
13.

[Clinical application of cyclooxygenase-2 inhibitors].

Dzielska-Olczak M, Olczak S.

Pol Merkur Lekarski. 2001 Jun;10(60):480-2. Review. Polish.

PMID:
11503270
14.

Nephrotoxic potential of selective cyclooxygenase-2 inhibitors.

Sandhu GK, Heyneman CA.

Ann Pharmacother. 2004 Apr;38(4):700-4. Epub 2004 Feb 24. Review.

PMID:
14982980
15.

Cyclooxygenase-2 inhibitor-associated acute renal failure: case report with rofecoxib and review of the literature.

Morales E, Mucksavage JJ.

Pharmacotherapy. 2002 Oct;22(10):1317-21. Review.

PMID:
12389882
16.

COX-2-specific inhibitors and the kidney: effect on hypertension and oedema.

Whelton A.

J Hypertens Suppl. 2002 Sep;20(6):S31-5. Review.

PMID:
12683425
18.

Cyclooxygenase-2 inhibitor treatment of older osteoarthritis patients.

Andersen SJ.

Compr Ther. 2003 Winter;29(4):215-23. Review.

PMID:
14989043
19.

Current perspective on the cardiovascular effects of coxibs.

Konstam MA, Weir MR.

Cleve Clin J Med. 2002;69 Suppl 1:SI47-52. Review.

PMID:
12086293
20.

Renal effects of nonselective NSAIDs and coxibs.

Weir MR.

Cleve Clin J Med. 2002;69 Suppl 1:SI53-8. Review.

PMID:
12086295

Supplemental Content

Support Center